Nodal T Follicular Helper Cell Lymphoma Follicular Type C2700204
A rare type of non-Hodgkin lymphoma affecting immune cells in the lymph nodes. Typically occurs in adults and is treated with chemotherapy, immunotherapy, or targeted therapies depending on the stage.
Key facts at a glance
- ICD-10
- C96.9
- ICD-11
- 2A00.0
- Body system
- hematologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Bone marrow involvement
Generalized symptoms
(hematologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Painless lymphadenopathy
(hematologic)Fever
(hematologic)Night sweats
(hematologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Combination chemotherapy regimen
Multi-agent chemotherapy protocols typically including anthracyclines and alkylating agents designed to achieve complete remission in aggressive lymphoma.
Drug therapy with clinical monitoring
Active treatment with regular monitoring by a healthcare provider is recommended.
Immunotherapy with monoclonal antibodies
Targeted therapy using anti-CD antibodies that enhance immune-mediated destruction of malignant T-follicular helper cells.
Additional treatment options
Radiation therapy
Localized radiation targeting involved lymph node regions, particularly for early-stage disease or residual disease after chemotherapy.
procedureAutologous stem cell transplantation
High-dose chemotherapy followed by stem cell rescue for eligible patients with relapsed or refractory disease achieving remission.
surgicalSurveillance imaging and labs
Regular PET-CT scans and tumor markers to detect relapse early, typically performed every 3-6 months for the first two years.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Nodal T Follicular Helper Cell Lymphoma Follicular Type C2700204?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Nodal T Follicular Helper Cell Lymphoma Follicular Type C2700204. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy